SEOUL, May 18 (Korea Bizwire) — South Korean pharmaceutical companies are scrambling to enter the so-called ‘petconomy’ market, or market for pet merchandise. Last week, drugmaker Yuhan Corp. introduced GedaCure, the country’s first drug to treat Cognitive Dysfunction Syndrome (CDS) in pets. South Korean cancer immunotherapy drug company Vaxcell-Bio Therapeutics Co. recently completed clinical trials [...]
SEOUL, Aug. 3 (Korea Bizwire) — South Korean pharmaceutical and bio-pharma companies are facing criticism that they are racing to boost share prices with half-cooked COVID-19 candidate treatments, and are likely to leave investors out in the cold. The nation’s pharmaceutical and bio-pharma companies are going all-out to have a higher position on real-time search [...]
SEOUL, March 30 (Korea Bizwire) — Pharmaceutical companies are stepping up “digital marketing” as the spread of COVID-19 has made it difficult to sell and market face-to-face with customers. A web seminar held recently by Novartis Korea attracted 985 people, 10 times more than usual. The web seminar was held under the theme of “The [...]
SEOUL, Mar. 18 (Korea Bizwire) — Several South Korean pharmaceutical companies have decided to make new facility investments in a bid to hone their competitiveness, industry sources said Monday. The decisions, made at annual shareholder meetings, are seen as reflecting their efforts to streamline and expand infrastructure for research and development (R&D), as well as [...]
SEOUL, Jan. 22 (Korea Bizwire) — Exports of drug-manufacturing technologies by South Korean pharmaceutical and bio companies reached nearly 5.3 trillion won (US$4.7 billion) in 2018 thanks to their efforts to tap into overseas markets, government data showed Tuesday. According to the data by the Ministry of Health and Welfare, industry player Yuhan Corp. and [...]
SEOUL, Jan. 21 (Korea Bizwire) — South Korean pharmaceutical companies are expressing grave concern as a recent Supreme Court decision may freeze the development of certain incrementally modified drugs. For long, pharmaceutical companies in South Korea have been releasing modified drugs that change certain saline substances, the strength, and dosage regimen of the original drug [...]
SEOUL, Nov. 5 (Korea Bizwire) — Pharmaceutical companies are facing controversy as they were found to be avoiding manufacturing certain medicines for which authorities issued sales permits upon condition that they would be used for clinical trials on patients, if market reaction was ‘not good enough’. Rep. Jang Jeong-sook of the ruling Democratic Party, a [...]
SEOUL, Aug. 16 (Korea Bizwire) — Major South Korean pharmaceutical companies expanded their spending on research and development (R&D) during the first half this year, with Hanmi Pharmaceutical Co. allocating the most, industry data showed Wednesday. According to their semi-annual business reports, 10 out of the 15 drug companies spent more on R&D during the [...]